Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: Effect of dietary fat and cholesterol

Biochimica et Biophysica Acta - Lipids and Lipid Metabolism

Volumn 1393, Issue 1, 1998, Pages 63-79

  Burnett, John R ^a   Wilcox, Lisa J ^a   Telford, Dawn E ^a   Kleinstiver, Sandra J ^a   Barrett, P Hugh R ^b   Huff, Murray W ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Acyl coenzyme A:cholesterol acyltransferase inhibitor; Apolipoprotein B metabolism; Cholesteryl ester; DuP 128; Kinetics; mRNA

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; LECIMIBIDE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTERIFICATION; CONTROLLED STUDY; ENZYME ACTIVITY; INTRAVENOUS DRUG ADMINISTRATION; LIPID DIET; LIVER LEVEL; NONHUMAN; PRIORITY JOURNAL; SWINE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEINS B; CHOLESTEROL, DIETARY; DIETARY FATS; DOWN-REGULATION; ENZYME INHIBITORS; IMIDAZOLES; INTESTINES; LIPOPROTEINS, VLDL; LIVER; STEROL O-ACYLTRANSFERASE; SWINE; SWINE, MINIATURE; UREA;

ANIMALIA; SUS SCROFA;

EID: 0032584551     PISSN: 00052760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2760(98)00059-9     Document Type: Article

References (87)

1. Kwiterovich P.O. Jr., Coresh J., Bachorik P.S. Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged ≤50 years) and women (aged ≤60 years) with coronary heart disease. Am. J. Cardiol. 71:1993;631-639.
2. Sniderman A.D., Shapiro S., Marpole D., Malcolm I., Skinner B., Kwiterovich P.O. Jr. The association of coronary atherosclerosis and hyperapobetalipoproteinemia (increased protein but normal cholesterol content in human plasma low density lipoprotein). Proc. Natl. Acad. Sci. USA. 97:1980;604-608.
3. Arad Y., Ramakrishnan R., Ginsberg H.N. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production. J. Lipid Res. 31:1990;567-582.
4. Teng B., Sniderman A.D., Soutar A.K., Thompson G.R. Metabolic basis of hyperapobetalipoproteinemia: turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. J. Clin. Invest. 77:1986;663-672.
5. Venkatesan S., Cullen P., Pacy P., Halliday D., Scott J. Stable isotopes show a direct relationship between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler. Thromb. 13:1993;1110-1118.
6. Janus E.D., Nicoll A.M., Turner P.R., Magill P., Lewis B. Kinetic bases of the primary hyperlipidemias: studies of apoB turnover in genetically defined subjects. Eur. J. Clin. Invest. 10:1980;161-172.
7. Kissebah A.H., Alfarsi S., Adams P.W. Integrated regulation of very low density lipoprotein triglyceride and apoB kinetics in man: normolipidemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Metabolism. 30:1981;856-868.
8. Vega G.L., Denke M.A., Grundy S.M. Metabolic basis of primary hypercholesterolemia. Circulation. 84:1991;118-128.
9. Cummings M.H., Watts G.F., Umpleby M., Hennessy T.R., Quiney J.R., Sönksen P.H. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study. Atherosclerosis. 113:1995;79-89.
10. Huff M.W., Burnett J.R. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion. Curr. Opin. Lipidol. 8:1997;138-145.
11. Ginsberg H.N. Synthesis and secretion of apolipoprotein B from cultured liver cells. Curr. Opin. Lipidol. 6:1995;275-280.
12. Sniderman A.D., Cianflone K. Substrate delivery as a determinant of hepatic apoB secretion. Arterioscler. Thromb. 13:1993;629-636.
13. Wetterau J.R., Aggerbeck L.P., Bouma M., Eisenberg C., Munck A., Hermier M., Schmitz J., Gay G., Rader D.J., Gregg R.E. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science. 258:1992;999-1001.
14. Sharp D., Blinderman L., Combs K.A., Kienzie B., Ricci B., Wager-Smith K., Gil C.M., Turck C.W., Bouma M., Rader D.J., Aggerbeck L.P., Gregg R.E., Gordon D.A., Wetterau J.R. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature. 365:1993;65-69.
15. Bóren J., Wettesten M., Sjober A., Thorlin T., Bondjer G., Wiklund D., Olofsson S. The assembly and secretion of apoB 100-containing lipoproteins in HepG2 cells: evidence for different sites for protein synthesis and lipoprotein assembly. J. Biol. Chem. 265:1990;10556-10564.
16. Segrest J.P., Jones M.K., Mishra V.K., Anantharamaiah G.M., Garber D.W. ApoB-100 has a pentapartite structure composed of three amphipathic alpha-helical domains alternating with two amphipathic beta-strand domains. Detection by computer program LOCATE. Arterioscler. Thromb. 14:1994;1674-1685.
17. McLeod R.S., Wang Y., Wang S., Links P., Yao Z. Apolipoprotein B sequence requirements for hepatic very low density lipoprotein assembly: evidence that hydrophobic sequences within apoB48 mediate lipid recruitment. J. Biol. Chem. 271:1996;18445-18455.
18. Jamil H., Dickson J.K. Jr., Chu C., Lago M.W., Rinehart J.K., Biller S.A., Gregg R.E., Wetterau J.R. Microsomal triglyceride transfer protein. Specificity of lipid binding and transport. J. Biol. Chem. 270:1995;6549-6554.
19. Wang S., McLeod R.S., Gordon D.A., Yao Z. The microsomal triglyceride transfer protein facilitates assembly and secretion of apolipoprotein B-containing lipoproteins and decreases cotranslational degradation of apolipoprotein B in transfected COS-7 cells. J. Biol. Chem. 271:1996;14124-14133.
20. Sakata N., Wu X., Dixon J.L., Ginsberg H.N. Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells. J. Biol. Chem. 268:1993;22967-22970.
21. Borchardt R.A., Davis R.A. Intrahepatic assembly of very low density lipoproteins: rate of transport out of the endoplasmic reticulum determines rate of secretion. J. Biol. Chem. 262:1987;16394-16402.
22. Sato R., Imanaka T., Takatsuki A., Takano T. Degradation of newly synthesized apolipoprotein B-100 in a pre-Golgi compartment. J. Biol. Chem. 265:1990;11880-11884.
23. Bóren J., Rustaeus S., Wettesten M., Andersson M., Wiklund A., Olofsson S. Influence of triacylglycerol biosynthesis rate on the assembly of apoB-100-containing lipoproteins in Hep G2 cells. Arterioscler. Thromb. 13:1993;1743-1754.
24. Dixon J.L., Furukawa S., Ginsberg H.N. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J. Biol. Chem. 266:1991;5080-5086.
25. Furukawa S., Sakata N., Ginsberg H.N., Dixon J.L. Studies of the sites of intracellular degradation of apolipoprotein B in HepG2 cells. J. Biol. Chem. 267:1997;22630-22638.
26. Tanaka M., Jingami H., Otani H., Cho M., Ueda Y., Arai H., Nagano Y., Doi T., Yokode M., Kita T. Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester contents in rabbit hepatocytes. J. Biol. Chem. 268:1993;12713-12718.
27. Sparks J.D., Sparks C.E. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochim. Biophys. Acta. 1215:1994;9-32.
28. Yao Z., McLeod R.S. Synthesis and secretion of hepatic apolipoprotein B-containing lipoproteins. Biochim. Biophys. Acta. 1212:1994;152-166.
29. Pullinger C.R., North J.D., Teng B.B., Rafici V.A., Ronhild de Brito A.E., Scott J. The apo B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J. Lipid Res. 30:1989;1065-1077.
30. Wu X., Sakata N., Dixon J., Ginsberg H.N. Exogenous VLDL stimulates apolipoprotein B secretion from HepG2 cells by both pre- and post-translational mechanisms. J. Lipid Res. 35:1994;1200-1210.
31. Hennessy L.K., Osada J., Ordovas J.M., Nicolosi R.J., Stucchi A.F., Brousseau M.E., Schaefer E.J. Effects of dietary fats and cholesterol on liver lipid content and hepatic apolipoprotein A-I, and E and LDL receptor mRNA levels in cebus monkeys. J. Lipid Res. 33:1992;351-360.
32. Furukawa S., Hirano T. Rapid stimulation of apolipoprotein B secretion by oleate is not associated with cholesteryl ester biosynthesis in HepG2 cells. Biochim. Biophys. Acta. 1170:1993;32-37.
33. Wu X., Sakata N., Lui E., Ginsberg H.N. Evidence for a lack of regulation of the assembly and secretion of apoliprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester. J. Biol. Chem. 269:1994;12375-12382.
34. Gibbons G.F., Khurana A., Odwell A., Seelaender M.C.L. Lipid balance in HepG2 cells: active synthesis and impaired mobilization. J. Lipid Res. 35:1994;1801-1808.
35. Thompson G.R., Naoumova R.P., Watts G.F. Role of cholesterol in regulating apolipoprotein B secretion by the liver. J. Lipid Res. 37:1996;439-447.
36. Avramoglu R.K., Cianflone K., Sniderman A.D. Role of the neutral lipid accessible pool in the regulation of secretion of apoB-100 lipoprotein particles by HepG2 cells. J. Lipid Res. 36:1995;2513-2528.
37. Qin W., Infante J., Wang S., Infante R. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes. Biochim. Biophys. Acta. 1127:1992;57-66.
38. Kosykh V.A., Preobrazhensky S.N., Fuki I.V., Zaikinal A.E., Tsibulsky V.P., Repin V.S., Smirnov V.N. Cholesterol can stimulate secretion of apolipoprotein B in cultured human hepatocytes. Biochim. Biophys. Acta. 836:1985;385-389.
39. Reinhart M.P., Billheimer J.T., Faust J.R., Gaylor J.L. Subcellular localization of the enzyme of cholesterol biosynthesis and metabolism in the rat liver. J. Biol. Chem. 282:1987;9649-9655.
40. Balaubramaniam S., Venkatesan S., Mitropoulos K.A., Peters T.L. The submicrosomal localization of acyl-coenzyme A:cholesterol acyltransferase and its substrate, and of cholesteryl esters in rat liver. Biochem. J. 174:1978;863-872.
41. Bell R.M., Coleman R.A. Enzymes of glycerolipid synthesis in eukaryotes. Annu. Rev. Biochem. 49:1980;459-487.
42. Glaumann H., Dallner G. Lipid composition and turnover of rough and smooth microsomal membranes in rat liver. J. Lipid Res. 9:1968;720-729.
43. Cianflone K.M., Yasruel Z., Rodriguez M.A., Vas D., Sniderman A.D. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesterol ester synthesis in the response to a fatty acid challenge. J. Lipid Res. 31:1990;2045-2055.
44. Musanti R., Giorgini L., Lovisolo P., Pirillo A., Chiari A., Ghiselli G. Inhibition of acyl-CoA:cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells. J. Lipid Res. 37:1996;1-14.
45. Krause B.R., Anderson M., Bisgaier C.L., Bocan T., Bousley R., DeHart P., Essenburg A., Hamelehle K., Homan R., Kieft K., McNally W., Stanfield R., Newton R.S. In vivo evidence that the lipid-regulating activity of the ACAT inhibitor CI-976 in rats is due to inhibition of both intestinal and liver ACAT. J. Lipid Res. 34:1993;279-294.
46. Krause B.R., Pape M.E., Kieft K., Auerbach B., Bisgaier C.L., Homan R., Newton R.S. ACAT inhibition decreases LDL cholesterol in rabbits fed a cholesterol-free diet. Marked changes in LDL cholesterol without changes in LDL receptor mRNA abundance. Arterioscler. Thromb. 14:1994;598-604.
47. Fukushima H., Anono S., Nakamura Y., Endo M., Imai T. The effect of N-(alpha-methylbenzyl)linoleamide on cholesterol metabolism in rats. J. Atheroscler. Res. 10:1969;403-414.
48. Heider J.G., Pickens C.E., Kelly L.A. Role of acyl-CoA:cholesterol acyltransferase in cholesterol absorption and its inhibition by 57-118 in the rabbit. J. Lipid Res. 24:1983;1127-1134.
49. Meiner V.L., Cases S., Myers H.M., Sande E.R., Bellosta S., Schambelan M., Pitas R.E., McGuire J., Herz J., Farese R.V. Jr. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc. Natl. Acad. Sci. USA. 93:1996;14041-14046.
50. Huff M.W., Telford D.E., Barrett P.H.R., Billheimer J.T., Gillies P.J. Inhibition of hepatic ACAT decreases apoB secretion in miniature pigs fed a cholesterol-free diet. Arterioscler. Thromb. 14:1994;1498-1508.
51. Carr T.P., Hamilton R.L. Jr., Rudel L.L. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys. J. Lipid Res. 36:1995;25-36.
52. Clark S.B., Tercyak A.M. Reduced cholesterol transmucosal transport in rats with inhibited mucosal acyl CoA:cholesterol acyltransferase and normal pancreatic function. J. Lipid Res. 25:1984;148-159.
53. Harnett K.M., Walsh C.T., Zhang L. Effects of Bay o 2752, a hypocholesterolemic agent, on intestinal taurocholate absorption and cholesterol esterification. J. Pharmacol. Exp. Ther. 251:1989;502-509.
54. Tso P., Morshed K.M., Nutting D.F. Importance of acyl-CoA: cholesterol acyltransferase (ACAT) in the esterification of cholesterol by enterocytes. FASEB J. 5:1991;709.
55. Windler E., Rucker W., Greeve J., Reimitz H., Greten H. Influence of the acyl-coenzyme A:cholesterol acyltransferase inhibitor octimibate on cholesterol transport in rat mesenteric lymph. Arzneim.-Forsch./Drug Res. 40:1990;1108-1111.
56. Grundy S.M., Denke M.A. Dietary influences on serum lipids and lipoproteins. J. Lipid Res. 31:1990;1149-1172.
57. Carr T.P., Parks J.S., Rudel L.L. Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis. Arterioscler. Thromb. 12:1992;1274-1283.
58. Huff M.W., Telford D.E., Woodcroft K., Strong W.L.P. Mevinolin and cholestyramine inhibit the direct synthesis of low density lipoprotein apolipoprotein B in miniature pigs. J. Lipid Res. 26:1985;1175-1186.
59. Higley C.A., Wilde R.G., Maduskuie T.P., Johnson A.L., Pennev P., Billheimer J.T., Robinson C.S., Gillies P.J., Wexler R.R. J. Med. Chem. 37:1994;3511-3522.
60. Huff M.W., Telford D.E., Barrett P.H.R. Dietary fish oil plus lovastatin decreases both VLDL and LDL apo B production in miniature pigs. Arterioscler. Thromb. 12:1992;902-910.
61. Huff M.W., Telford D.E. Direct synthesis of low-density lipoprotein apoprotein B in the miniature pig. Metabolism. 34:1985;36-42.
62. Egusa G., Brady D.W., Grundy S.M., Howard B.V. Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B. J. Lipid Res. 24:1983;1261-1267.
63. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226:1957;497-509.
64. Billheimer J.T., Tavani D., Nes W.R. Effect of a dispersion of cholesterol in triton WR-1339 on acyl CoA:cholesterol acyltransferase in rat liver microsomes. Anal. Biochem. 111:1981;331-335.
65. Rustan A.C., Nossen J.O., Christiansen E.N., Drevon C.A. Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyltransferase. J. Lipid Res. 29:1988;1417-1426.
66. Azrolan N., Breslow J.L. A solution hybridization/RNase protection assay with riboprobes to determine absolute levels of apoB, A-I, and E mRNA in human hepatoma cell lines. J. Lipid Res. 31:1990;1141-1146.
67. Weintraub M.S., Eisenberg S., Breslow J.L. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III and type IV hyperlipoproteinemic individuals: effects of treatment with cholestyramine and gemfibrozil. J. Clin. Invest. 79:1987;1110-1119.
68. Kieft K.A., Bocan T.M.A., Krause B.R. Rapid on-line determination of cholesterol distribution among plasma lipoproteins after high-performance gel filtration chromatography. J. Lipid Res. 32:1991;859-866.
69. G.W. Snedecor, W.G. Cochran, in G.W. Snedecor, W.G. Cochran (Eds.), Statistical Methods, Iowa State University Press, Iowa, 1967, pp. 94-97.
70. Dashti N. The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells. J. Biol. Chem. 267:1992;7160-7169.
71. Gillies P.J., Robinson C.S., Rathgeb K.A. Regulation of ACAT activity by a cholesterol substrate pool during the progression and regression phases of atherosclerosis: implications for drug discovery. Atherosclerosis. 83:1990;177-185.
72. Bocan T.M.A., Mueller S.B., Uhlendorf P.D., Brown E.Q., Mazur M.J., Black A.E. Inhibition of acyl-CoA cholesterol O-acyltransferase reduces cholesterol ester enrichment of atherosclerotic lesions in the Yucatan micropig. Atherosclerosis. 99:1993;175-186.
73. Hainer J.W., Terry J.G., Connell J.M., Zyruk H., Jenkins R.M., Shand D.L., Gillies P.J., Livak K.J., Hunt T.L., Crouse J.R. III. Effect of the acyl-CoA:cholesterol acyltransferase DuP 128 on cholesterol absorption and serum cholesterol in humans. Clin. Pharmacol. Ther. 56:1994;65-74.
74. Spring D.J., Chen-Liu L.W., Chatterton J.E., Elovson J., Schumaker V.N. Lipoprotein assembly. Apolipoprotein B size determines lipoprotein core circumference. J. Biol. Chem. 267:1992;14839-14845.
75. Gordon D.A., Jamil H., Sharp D., Mullaney D., Yao Z., Gregg R.E., Wetterau J. Secretion of apolipoprotein B-containing lipoproteins from HeLa cells is dependent on expression of the microsomal triglyceride transfer protein and is regulated by lipid availability. Proc. Natl. Acad. Sci. USA. 91:1994;7628-7632.
76. Bóren J., Graham L., Wettesten M., Scott J., White A., Olofsson S. The assembly and secretion of apoB 100-containing lipoproteins in Hep G2 cells. ApoB 100 is cotranslationally integrated into lipoproteins. J. Biol. Chem. 267:1992;9858-9867.
77. Yao Z., Vance D.E. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J. Biol. Chem. 263:1988;2998-3004.
78. Goldstein J.L., Brown M.S. Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol. J. Lipid Res. 25:1984;1450-1461.
79. Venkatesan S., Mitropoulos K.A., Balaubramaniam S., Peters T.L. Biochemical evidence for the heterogeniety of membranes from rat liver endoplasmic reticulum: studies on the localization of acyl-CoA:cholesterol acyltransferase. Eur. J. Cell. Biol. 21:1980;167-177.
80. Middleton B. Inhibition of cellular cholesterol esterification can decrease low density lipoprotein number in fibroblasts. Biochem. Biophys. Res. Commun. 145:1987;350-355.
81. Havekes L.M., de Wit E.C.M., Princen H.M.G. Cellular free cholesterol in HepG2 cells is only partially available for downregulation of low density lipoprotein receptor activity. Biochem. J. 247:1987;739-746.
82. Cohn J.S. Postprandial lipid metabolism. Curr. Opin. Lipidol. 5:1994;185-190.
83. Abbott W.G.H., Swinburn B., Ruotolo G. Effect of a low carbohydrate, low-saturated-fat diet on apolipoprotein B and triglyceride metabolism in Pima Indians. Metabolism. 86:1990;642-650.
84. 2 and VLDL-B in human subjects consuming high carbohydrate diets. Metabolism. 31:1982;493-498.
85. Ginsberg H.N., Le N., Melish J. Effect of a high carbohydrate diet on apolipoprotein-B catabolism in man. Metabolism. 30:1980;347-353.
86. Fernandez M.L., Sun D.M., Montano C., McNamara D.J. Carbohydrate-fat exchange and regulation of hepatic cholesterol and plasma lipoprotein metabolism in the guinea pig. Metabolism. 44:1995;855-864.
87. Daumerie C.M., Woolett L.A., Dietschy J.M. Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools. Proc. Natl. Acad. Sci. USA. 89:1992;10797-10801.